Uncategorized
Sanofi gains AATD hopeful with $1.7-billion deal for Inhibrx
sanofi, Inhibrx, Acquisition (action), alpha 1-Antitrypsin Deficiency, Market
Bristol Myers’ Opdivo fails part two of post-kidney cancer surgery test as competitor Merck touts new survival data
Bristol, Myers, Opdivo, post-kidney cancer surgery test, Continuance of life
AbbVie pours $223M into building out its biologics capacity in Singapore
Biological Factors, expansion, AbbVie, Capacity, Investments, Manufacture, Singapore
Merck details win for Keytruda in bladder cancer after surgery
Keytruda, Malignant neoplasm of urinary bladder, Surgery specialty
Talc marketing claims against J&J close to potential settlement with 40+ states
Settlement and Resettlement, Johnson and Johnson, J&J’s
Shanghai startup’s gene therapy restores hearing in five deaf children, running ahead of Lilly and Regeneron trials
Child, Hearing, Hearing Impaired Persons, gene therapy
Eli Lilly says its potential gene therapy ‘restored hearing’ in 11-year-old boy
Hearing, Eli, Boys, 11-year-old
Annovis says ‘data cleaning’ postpones buntanetap readout in Parkinson’s
buntanetap, Annovis, Parkinson’s
Lonza closes plant in China but CDMO’s sales signal an uptick in industry
Plants, China, Signal, Industry, Congestive heart failure